Liste von Medikamenten zur Behandlung in Von Serbien:
Adenocarcinoma Of Renal CellsCancer,Hairy Cell LeukemiaCarcinomaChildhood Non-Hodgkin LymphomaChronic Active HepatitisChronic HepatitisChronic Hepatitis BChronic Hepatitis CChronic Myeloid LeukemiaCutaneous T-Cell LymphomaHairy Cell LeukemiaHepatitisHepatitis BHepatitis CHodgkin LymphomaHypernephromaKaposi'S SarcomaLeukemiaLymphomaMalignant MelanomaSurgery
Medizinisch geprüft von Kovalenko Svetlana Olegovna Zuletzt aktualisiert am 16.01.2020
Russische Föderation
Inhaltsstoffe
Interferon Alfa-2a
Behandlungsmöglichkeit
Therapeutische Anwendung
gleich
gleich
gleich
Serbien
Inhaltsstoffe gleich
Interferon Alfa-2a
Behandlungsmöglichkeit gleich
Therapeutische Anwendung gleich
Apotheken in meiner Nähe anzeigen
Pillintrip.com ist keine Apotheke!
Andere Analoga
| Name | Inhaltsstoffe | Behandlungsmöglichkeit | Therapeutische Anwendung | ||
| Roferon-A | 100% | ||||
 Proscar | 60% | ||||
| Vesanoid | 60% | ||||
| Adriblastina RD | 60% | ||||
| Campto | 60% | ||||
| Carboplatin | 60% | ||||
| Daunoblastina(Daunorubicin) | 60% | ||||
| Endoxan | 60% | ||||
| Etoposid Ebewe | 60% | ||||
| Evitol | 60% | ||||
| Femara | 60% | ||||
| Femozol | 60% | ||||
| Finastep | 60% | ||||
| Finpros | 60% | ||||
| Flutasin | 60% | ||||
| Glivec | 60% | ||||
| Herceptin | 60% | ||||
| Imuran | 60% | ||||
| Irenax | 60% | ||||
| Karboplatin | 60% | ||||
| Lametta | 60% | ||||
| Lastet | 60% | ||||
| Mabthera | 60% | ||||
| Nexavar | 60% | ||||
| Nolvadex | 60% | ||||
| Nolvadex D | 60% | ||||
| Nolvadex-D | 60% | ||||
| Paclitaxel-Teva | 60% | ||||
| Pataxel | 60% | ||||
| Pegasys | 60% | ||||
| PegIntron | 60% | ||||
| Prosterid (Finasteride) | 60% | ||||
| Sindovin | 60% | ||||
| Sutent | 60% | ||||
| Tamoxifen Alvogen | 60% | ||||
| Taxol | 60% | ||||
| Taxotere | 60% | ||||
| Temodal | 60% | ||||
| Velcade | 60% | ||||
| Vepesid | 60% | ||||
| Vinblastin | 60% | ||||
| Votrient | 60% | ||||
| Xeloda | 60% | ||||
| Daunoblastina | 60% | ||||
| Litalir | 60% | ||||
| Prosterid | 60% | ||||
| Intron A | 50% | ||||
| Intron-A | 50% |
